HomeSCPI • IDX
add
Organon Pharma Indonesia Tbk PT
Market news
Financials
Income Statement
Revenue
Net income
| (IDR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 847.26B | 28.84% |
Operating expense | 16.92B | 39.05% |
Net income | 50.44B | -21.31% |
Net profit margin | 5.95 | -38.97% |
Earnings per share | — | — |
EBITDA | 72.89B | -17.95% |
Effective tax rate | 24.47% | — |
Balance Sheet
Total assets
Total liabilities
| (IDR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 157.47B | 22.98% |
Total assets | 1.91T | 15.07% |
Total liabilities | 749.46B | 5.34% |
Total equity | 1.16T | — |
Shares outstanding | 3.60M | — |
Price to book | 0.09 | — |
Return on assets | 8.56% | — |
Return on capital | 14.39% | — |
Cash Flow
Net change in cash
| (IDR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 50.44B | -21.31% |
Cash from operations | -4.87B | 89.91% |
Cash from investing | 4.95B | 121.82% |
Cash from financing | -773.67M | -154.31% |
Net change in cash | -760.00M | 98.91% |
Free cash flow | -23.77B | 71.16% |
About
Founded
1972
Website
Employees
179
